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 Abstract 
Objectives. To evaluate the feasibility of an interventional study involving a seated plantar 
resistance exercise programme, using a StepIt pedal, aimed at promotion of venous leg 
ulcer (VLU) healing.  
Methods. Thirty-two VLU patients, recruited from community, GP and hospital settings,  
were randomised to either a standard care or adjuvant StepIt exercise programme arm for 
up to 12 weeks. The exercise involved a twice daily routine of ten times one-minute of 
exercise, i.e. two-second push and two-second lift repetitions (equating to 300 daily ‘steps’). 
Results. Complete healing of the VLU was observed in 10 out of 15 (67%; StepIt cohort) and 
7 out of 17 (41%; control cohort) respectively (p-value 0.18, Fisher’s exact test). Baseline 
differences between the two cohorts were longer wound chronicity, less VLU-related pain, 
and better VLU-related quality of life in the StepIt cohort. One adverse event, involving 
increased wound exudate and slough production, was observed in a participant using StepIt, 
and no study withdrawals were recorded in either arm.  StepIt users whose wound had 
completely healed by week 12 were more likely to be compliant with the exercise 
programme (self-reported) and more positive about the trial experience; however, all would 
recommend the device to others.  
Conclusions: seated plantar resistance exercise shows promise and may accelerate VLU 
wound healing. The StepIt pedal is well-received by patients, and its efficacy may depend on 
the degree of patient compliance with the exercise programme. Further larger scale studies 
are indicated to allow more concrete inferences to be made on the clinical and potential 
health economics impact that this device may have. 
A multicentre randomised research trial assessing the effectiveness and acceptability of a 
calf muscle exercise device for supportive treatment of venous leg ulcers, ISRCTN75319519, 
https://doi.org/10.1186/ISRCTN75319519 
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 Background 
Venous leg ulcers (VLUs) are the most common type of leg ulcers, affecting 1-3% of the 
population over 60 years and this incidence is expected to increase with an aging 
population.[1,2] The economic burden of VLUs is considerable, with annual care costs in the 
UK alone reaching £200 million.[3] A positive relationship has been observed between 
occurrence and specific modern lifestyle risk factors such as sedentary lifestyles and 
obesity.[4] The natural history of the disease is a continuous cycle of healing and breakdown 
over decades and VLUs are associated with considerable; expense, morbidity and impaired 
quality of life.[5]  
Despite extensive research, the exact manner in which VLUs develop is not yet fully 
understood. However, prolonged venous hypertension caused by chronic venous 
insufficiency is a common aetiological factor.[6,7] The mainstay of treatment of VLUs is the 
reversal of venous hypertension through compression bandaging,[8] however up to 15-30% 
do not respond to this current gold standard treatment and remain unhealed even after six 
months of treatment.[9,10] Venous return is also facilitated by the action of the foot and calf 
muscle pump; previous studies have shown that patients with VLUs have histopathological 
changes of degeneration in the calf muscle and impaired calf muscle function.[11, 12, 13] There 
is evidence that exercise of said muscle can improve physiological functioning. Exercises 
such as heel raises, flexion, extension and rotation of the ankles have been shown to 
increase venous return;[14, 15, 16, 17, 18] in addition, clinical guidelines recommend supervised 
ankle exercises and walking.[1]  
Patients with venous leg ulcers report multiple co-morbidities and are more likely to be 
sedentary than age matched controls.[5, 15] Whilst exercise could be of particular benefit for 
this group of patients, research suggests that around 50% of sedentary adults who start an 
exercise programme stop within the first six months of involvement.[19]  There is therefore 
an unmet need for a calf muscle exercise option for patients who may be receptive to 
exercise but may struggle with more strenuous walking or other exercises that involve 
standing for longer periods. This may be the case for patients who are elderly, frail, have 
limited mobility, have a fear of falling or are housebound. The present study offered a 
plantar resistance rocker pedal, called StepIt, to patients with VLUs in an adjuvant therapy 
to compression therapy. The aim of this prospective, randomised, controlled, feasibility 
study was to determine the acceptability and initial efficacy of the StepIt pedal with a 
primary clinical outcome measure of complete VLU healing.  
 
Methods 
Study design 
The PREVUE feasibility study (short for PlantaR flexion Exercise for Venous Ulcer Evaluation) 
was a multi-centre, prospective, randomised controlled trial of an adjuvant StepIt exercise 
regime versus standard compression bandaging wound care involving patients with VLUs. 
Patients were enrolled in two NHS hospital Trusts, two GP practices and one community 
care NHS Trust in England. Full research governance clearance was obtained from the 
National Research Ethics Service (reference 17/WA/0103), Health Research Authority 
(reference 222694) and local NHS Trusts, and the study is registered on the International 
Standardised Clinical Trial Number registry under reference ISRCTN75319519.  
Eligibility criteria were that patients were aged 18 years or older, with a clinical diagnosis of 
VLU (ie a clinical severity score of C6 on the CEAP venous disease classification score[20]) and 
mental and linguistic capacity to participate. Additional exclusion criteria were limited life 
expectancy such as palliative care, not being able to tolerate compression, and an active 
infection of the VLU that required further treatment with e.g. antibiotics. All regular clinical 
criteria for compression bandaging applied. Written informed consent was obtained and 
participants were in the trial for 12 weeks, with study visits at week 0, week 6 and week 12. 
Following written consent, participants were allocated 1:1 at random to the control or 
StepIt intervention group, using a non-restricted randomised sequence generated for the 
whole sample using a freeware randomisation programme, see 
https://www.randomizer.org/ . The randomisation was stratified for VLU size, with one 
group being those with a PUSH score of 8 or lower and the other with a PUSH score of 9 or 
higher. Sequential envelopes with each next randomisation allocation were used to achieve 
concealment. As the study involved a self-administered intervention it was not possible to 
achieve blinding for the participants. Due to the pilot nature of this study, the researcher 
was not blinded either to the subjects’ intervention. 
Procedures 
The StepIt rocker pedal is a small pedal device that can be used from a seated position and 
was first devised with the aim to help alleviate the risk of deep vein thrombosis for 
travellers on long haul flights.[21] It has also been shown to have some potential 
effectiveness in patients with peripheral arterial disease.[22] This design is aimed to stimulate 
the calf muscles through plantar resistance and hence increase circulation in the legs. 
Resistance of the pedal is circa 6 kg and cannot be adjusted. There is no recommended 
tempo indicated for the pedal; however, in the VLU target population for the PREVUE trial, 
patients were be encouraged to work at – or towards -  a  two-second downwards, two-
second upwards motion frequency. In the study by Tebbutt et al[22],  encouraging results 
were obtained - in terms of increase in maximum walking distance for peripheral arterial 
disease patients who used the StepIt pedal – when a 20-minute exercise regime was 
prescribed. Therefore, for this study a similar approach was taken: the overall exercise 
programme was to exercise on the pedal with the index leg for one minute – then rest it for 
one minute – and to repeat this 10 times. In the rest period patients were allowed to 
exercise the other leg if desired. This regime was to be done twice daily (e.g. morning and 
evening). At a minimum recommended 2-second down and 2-second up pace this equates 
to at least 300 pedal movements for the index leg per day. Participants were asked not to 
exceed the recommended regime – to standardise the intervention and to minimise the risk 
of any patients potentially injuring themselves through excessive overuse - and to be seated 
on a chair or sofa whilst exercising. They were also asked to complete a paper daily 
compliance diary and also had the option to be reminded bi-weekly about the exercise 
regime by periodical text message from the trial team. 
Outcomes 
Since this concerns a feasibility study, aimed to determine the feasibility of a larger trial in 
the future, the primary objectives were to determine if patients could be recruited to the 
trial, and to determine which healthcare sites were best suited to this kind of trial. 
Furthermore, participant compliance with the StepIt exercise regime, the suitability of the 
exercise programme itself, and adequacy of the follow-up period in relation to clinical 
outcomes were assessed. The primary clinical outcome in relation to the efficacy of the 
StepIt pedal in relation to wound healing was complete healing at week 12. Wound healing 
was measured at weeks 0, 6, and 12, using a transparent wound measurement sheet and 
calculation of the area with Acrobat reader. A semi-quantitative measure of wound size was 
also made using the PUSH score.[23,24]  At all three study visits, including before 
randomisation at baseline, the following outcome measures were determined in addition to 
wound size: ankle range of motion, both plantarflexion and dorsiflexion, visual analogue 
pain score in relation to the VLU,  Quality of life score as determined by Charing Cross 
Venous Ulcer Questionnaire (Smith et al 2010).[25] Any adverse events, withdrawal, lost to 
follow-up and VLU infection rates were also recorded at follow-up. Serious adverse events 
were pre-defined in the protocol and the study was managed in accordance with good 
clinical practice. 
  
 
 
Statistical analysis 
No formal a priori sample size calculation was performed since this concerns a first 
feasibility trial of StepIt for VLUs. However, the recommended 12 participants per group was 
applied and an additional 30% attrition rate was anticipated in view of the twelve week 
follow-up period and multiple visits, resulting in a sample size of 32.[26] Data was analysed 
on an intention-to-treat basis, using the last value carried forward principle for the PUSH 
score variable, which was applicable for one control participant at week 12. Due to missing 
data at week 0, only per protocol data was analysed for wound size (cm2) and pain levels. 
Statistical analyses were two-sided and a p-value <0.05 was considered significant.  Due to 
the non-normal distribution of wound size data in particular, non-parametric tests were 
used for statistical analysis.  
 
Results 
From June 2017 to and including November 2018, 53 VLU patients were considered of which 
32 were randomised (Figure 1). CONSORT[27] data is presented in Figure 1. A total of 31 out 
of 32 (97%; one case lost to follow-up) completed the 12-week trial period and there were 
no withdrawals. One adverse event occurred in the StepIt cohort; a participant experienced 
a marked increase in exudate and slough produced by the VLU within one month of 
commencing the trial, and StepIt exercise was suspended for a week as a precaution. 
  
Figure 1, CONSORT flowchart of PREVUE feasibility trial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessed for eligibility (n= 53) 
Analysed (PUSH n= 17; wound size n = 13) 
- For wound size, excluded from analysis (due 
to lack of baseline data) (n= 4) 
Lost to follow-up (give reasons) (n= 1, did not 
attend wk 12) 
Withdrawn (n= 0) 
 
Allocated to standard care (n= 17) 
- Received allocated intervention: not applicable 
- Did not receive allocated: not applicable  
Lost to follow-up (give reasons) (n= 0) 
Withdrawn (n= 0) 
Allocated to StepIt intervention (n= 15) 
- Received allocated intervention (n= 15) 
- Did not receive allocated intervention (n= 0) 
Analysed (PUSH n= 15; wound size n =12) 
- For wound size, excluded from analysis (due 
to lack of baseline data) (n= 3) 
 
Randomisation 
Analysis 
Follow-Up 
Excluded  (n= 21) 
♦   Not meeting inclusion criteria 
(n=11) 
♦   Declined to participate (n= 2) 
♦   Other reasons, LFU (n= 8) 
Enrollment 
Informed consent (n= 32) 
 Table 1 shows information on demographics and clinical parameters at baseline for both the 
control and StepIt arm. On average, the VLUs of participants in the StepIt arm were 
significantly older than those in the control arm. Conversely, control patients experienced a 
poorer quality of life related to the wound at baseline (week 0). It was more challenging to 
obtain all relevant data in the community setting compared to GP practice and hospital 
settings; this contributed to not all demographic and clinical data being collated for all 
patients. Recruitment figures were as follows per setting: district nursing, 6 patients; GP 
practices, 5 patients; hospital (vascular surgery & dermatology departments), 21 patients. 
The PUSH score was obtained for all participants, whereas the wound size (using a 
measurement sheet) was not in all cases. In Table 2 the PUSH score is presented for the 
different time points and treatment arms. At no time point was there a significant 
difference between control and StepIt cohorts, though the p-value reduced as the trial 
progressed. The ‘wound healed’ status for control versus StepIt arms was compared at week 
12 (see Table 3). A positive trend was observed for those who were randomised to the 
StepIt arm, though the result was not significant at a p-value of 0.18.  At week 0, there was 
no difference in wound size between control (median 4.39 cm2, interquartile range [IQR] 
9.49) and StepIt (3.76 cm2, IQR 5.80), p-value 1.00. Again, at week 12 there was no 
significant difference observed, and the median and IQR value were 0.12 cm2 , 0.88, for the 
control arm and 0 cm2, 3.23, for StepIt (p-value 0.73). Figure 2a and 2b respectively outline 
the wound healing trajectory for each individual participant when plotted for PUSH score at 
week 0, 6 and 12. This illustrates the trend towards accelerated VLU healing in the StepIt 
cohort. Patients with VLU have a limited range of ankle movement because of decreases in 
both plantar flexion and dorsiflexion.[28] This decreased ankle mobility is associated with 
delayed VLU healing.[29] To determine if the range of movement was indeed severely 
impaired in the trial subjects, the plantarflexion and dorsiflexion angles were measured as 
part of the trial. Both average plantar and dorsiflexion motion were at the lower end of 
normal values of approximately 20-50° and 0-20° respectively,[34] but the values for the 
StepIt cohort were not significantly different from those in the control cohort (Table 1) and 
similar to those reported in VLU patients by Klonizakis et al.[17] 
 
[Figure 2a and 2b here] 
  
 
Table 1, Demographics and clinical parameters at baseline 
Variable Control arm [n] StepIt arm [n] 
Age in yrs, mean  (95% CI) 77 (71 to 82)  
[17] 
73 (69 to 78)  
[15] 
Sex, male / female, n  5 / 12  
[17] 
7 / 8  
[15] 
BMI in kg/m2, mean (95% CI) 
 
30.1 (25.9 to 34.4)  
[14] 
30.6 (26.8 to 34.5) 
[14] 
Smoking status, never / ex / current, n 9 / 4 / 1  
[14] 
10 / 2 / 2  
[14] 
Plantarflexion motion (degrees), mean / 
95% CI 
21 (17 to 25)  
[17] 
25 (19 to 31)  
[13] 
Dorsiflexion motion (degrees), mean / 
95% CI 
14 (10 to 18)  
[17] 
13 (7 to 20)  
[13] 
Chronicity wound in weeks , mean (95% 
CI) 
20 (0 to 41)  
 [13] 
42 (13 to 70)  
[11] 
VLU quality of life, median (interquartile 
range, IQR) 
65 (20) 
[17] 
52.5 (29.5) 
[14] 
 
 
 
 
 
 
 
Table 2, PUSH scores and wound sizes at different trial time points 
 Week 0   Week 6  Week 12   
Control n=17; StepIt n=15 Control  StepIt  Control  StepIt  Control  StepIt  
PUSH score, median (IQR) 11.0 (5.5)  9.0 (6)  7  (15) 8 (15)  2 (13)   0 (14)  
p-value  
(control vs StepIt)* 
0.88 0.78 0.45 
Control n=13; StepIt n=12 Control StepIt Control StepIt Control StepIt 
size cm2, median (IQR) 4.39 (9.49) 3.76 (5.80) 1.3 (4.81) 2.3 (4.57) 0.12 (0.88) 0 (3.23) 
p-value  
(control vs StepIt)* 
1.00 0.79 0.73 
*Mann-Whitney U-test 
 
Table 3, wound healed status  
Wound status at week 12 Control [n=17] StepIt [n=15] 
Healed 7  (41%) 10 (67%) 
Not healed 10 (59%) 5 (33%) 
Fisher exact test, p-value = 0.18 
 
 
 
 
Pain levels improved for both control and StepIt participants as they progressed through the  
trial; from a median 4 (out of 10 on visual analogue scale) at baseline to 2, and from 3 to 0 
respectively. There was no significant difference between the two treatment arms at either 
baseline or at 12 weeks (p-values of 0.058 at baseline and 0.40 at 12-weeks [n=14 vs 13]). In 
terms of other patient-related outcome measures, there were issues with participants 
reporting back with the exercise diary and requests for text reminders were very limited. 
Nine out of fifteen returned their diary at follow-up appointments (60% compliance) and 
two opted to be sent text reminders on StepIt use (13%). Of six diary responders who 
complied with the exercise programme > 80% of the trial days, four wounds were healed at 
12 weeks; amongst the three other surveyed who complied to a lesser degree, none of the 
wounds had healed at week 12. The overall feedback given by participants who were 
randomised to the StepIt arm was positive (see Figure 3); of the fifteen subjects in the StepIt 
arm, fourteen (93%) provided feedback. The majority of participants would recommend the 
StepIt pedal to others, and the overall experience of taking part in the trial was ‘good’ or 
‘excellent’. When stratified for wound status at week 12, those with healed VLUs were more 
positive about the healing of their wound and the contribution that the StepIt exercises may 
have had. Likewise, better self-reported compliance with the exercise regime appeared to 
correlate with better wound healing outcomes – the sample size being too small to test this 
statistically. Free-text feedback on StepIt pedal exercise included two notes on it being 
boring, one stating that it was hard to fit in the day, and one explaining that compliance was 
sub-optimal due to other health issues. 
Patient feedback on use of the StepIt pedal was one of the findings as part of this feasibility 
trial. Table 4 summarises other methodological topics that were appraised and what has 
been learned as a result of conducting the study. Various minor changes should allow future 
studies to be improved from a methodological point of view. 
[Figure 3 here] 
 
 
Table 4, Summary of trial feasibility findings 
Methodological issues Findings & notes 
Appropriateness eligibility and 
randomisation criteria 
Future studies should be more controlled, with minimum and 
maximum allowed VLU wound sizes applied, and stratification 
for wound chronicity in addition to wound size. 
Were clinical staff willing to 
recruit and follow-up patients? 
Positive experiences in GP practices and hospitals, whereas 
district nursing staff struggled to accommodate the clinical 
outcome measures (particularly wound size measurements with 
grid). Non-standardised care for VLU patients is challenging, 
with dermatology, tissue viability and vascular surgery 
departments all managing said patients. 
Was recruitment successful? Recruitment rate was slower than anticipated; 32 patients 
recruited in 17 month period, whereas aim was twelve months. 
Patients willing to participate in, 
and complete the trial?  
Out of 42 eligible patients approached, 10 either declined or 
failed to respond to an invite to take part in the trial. One 
participant lost to follow-up, otherwise all participants 
completed the trial (see Figure 1).   
Was a mean and standard 
deviation (SD) of the wound size 
obtained?  
At week 12, the mean (SD) was 0.54 cm2 (0.94) for the control 
arm and 8.62 cm2 (23.97) for the StepIt arm, see Table 2. Issue 
where VLU of one StepIt participant measured > 80cm2 (ie ten-
fold the mean VLU size).  
Intervention acceptable and 
complied with? 
All patients rated the trial experience good or excellent (see 
Figure 3). Sixty percent of participants completed exercise diary, 
with 6 out of 9 responders claiming to be >80% compliant. In 
survey at end of trial, 10 out of 14 participants claimed to have 
been compliant ‘most of the time’ or ‘all of the time’. One 
patient felt the exercise slightly boring, another struggled to fit 
it in around shift work.  
Possible to calculate 
intervention costs? 
Yes; each StepIt pedal would cost £15 at full retail price. 
Response rates to and suitability 
of clinical and patient-related 
outcome measures. 
No issues with response rates from participants, apart from for 
exercise diary. Digital counter for measuring StepIt device is 
desired. Clinical score such as Venous Clinical Severity Score 
would enhance information on patient status. It is desirable to 
replace wound tracing with digital measurement of wounds, 
provided this is logistically feasible. 
Appropriate outcome identified 
for definitive trial? 
If min-max VLU size at baseline is controlled for then status 
‘wound healed’ at week 12 would be a feasible outcome 
measure. Time to heal should be appraised in follow-up study 
with more timepoints and longer follow-up period. 
 
 
Discussion 
Literature suggests that there is a relationship between VLU severity and calf muscle pump 
dysfunction.[11, 12, 13] Therefore, the StepIt pedal – which offers resisted plantar flexion 
movement exercise with the patient seated - was used as an exercise intervention in this 
prospective, pilot, randomised, controlled trial. Other studies have shown that patients are 
able and willing to do home-based exercise[17,18] Unsupervised exercise would potentially be 
more economical than supervised exercise, as recommended by SIGN and used by 
others,[16,17,32] but only if said unsupervised exercise is effective, and as effective as 
supervised exercise, and safe. With only one adverse event reported, and a reduction in 
pain observed, thus far the use of StepIt does not appear to be associated with wound 
deterioration or be a source of discomfort. Nonetheless, the StepIt pedal will have to be 
used by many more patients – and possibly for longer periods – to establish its exact safety 
profile. Since VLU patients cite fear of harm due to exercise, the seated approach with the 
StepIt pedal may suit this patient population.[33] The recommended daily number of 600 
plantarflexion steps ‘prescribed’ in the current study is considerably less than the 6,500 
average number of regular steps reputedly taken by older adults.[34] However, we 
hypothesized that VLU patients will on average not come close to the reported numbers for 
the general public and that a too strenuous or lengthy regime could potentially lead to non-
compliance and withdrawal. On average, trial participants had a slight impairment in ankle 
movement at the start of the study. Although the sample was too small to draw conclusions, 
it appears that some limitation in ankle movement  should not necessarily preclude patients 
from using a plantarflexion resistance exercise device. Davies and colleagues[31]  reported an 
improvement in ankle range after a 24-week plantar resistance exercise programme; testing 
any change in ankle range of motion was not an objective in this study, but may be tested in 
the future in a larger cohort using StepIt. 
This present study had some recognised limitations, some of which could potentially be 
addressed in a larger trial. The researchers were not blinded either to the subjects’ 
intervention, and ideally a person blinded to this would be used to obtain research outcome 
data including patient-reported outcome measures. This could potentially reduce any bias, 
e.g. when measuring the VLU wound. Introducing a true sham treatment for participants in 
the control arm would be hard to achieve – even non-resistance plantar flexion will likely 
train the calf muscles to some degree.  However, the primary outcome measure, size of the 
VLU is a quantitative outcome measure which is less prone to bias than for example a 
patient reported outcome measure or a clinician reported outcome measure. There was a 
reliance on patient-reported compliance to the StepIt exercise regime. The addition of a 
counter to the pedal itself or a pedometer on the ankle may give more quantitative 
evidence on the amount of exercise that is done by each participant. This is of particular 
interest since – judging from our very limited sample - better compliance to the programme 
may possibly result in better healing outcomes. Thus far only one exercise regime has been 
trialled; further research may include trialling different regimes, eg variable days of the 
week that exercise is performed and/or time spent doing the exercise. One study objective 
was to determine if this kind of research can successfully take place in different care 
settings; in contrast to a hospital setting, it was more challenging to obtain all data in a 
community setting and this affected sample numbers for some variables that were 
evaluated. 
VLUs in the StepIt cohort were more chronic than in the control cohort; despite this being a 
known risk factor for delayed healing,[35] there was still a trend for wounds in the StepIt 
cohort to heal faster by week 12. Future research could include a longer trial period of 
around 18-26 weeks, to determine if more wounds heal by that time point and if long-term 
use of the StepIt pedal is feasible in view of some reporting that the exercise is slightly 
boring. Furthermore, a long-term wound status follow-up point should inform if plantar 
flexion exercise with the StepIt pedal can reduce the risk of VLU recurrence and need for 
surgical intervention since over 50% of patients will experience a recurrence within a 
year.[36]  
In summary, the results from this feasibility study add to the current evidence that exercise 
by a VLU patient at home can promote wound healing. Furthermore, this patient population 
is receptive to exercise and can be programme compliant – in this study 11/14 (78%) 
reported to comply most or all of the time, which is similar to compliance rates observed in 
a different (supervised) exercise trial.[17] As with other studies, a larger trial, focusing on 
healing as well as more long-term clinical outcomes is indicated to allow more definitive 
conclusions to be drawn. 
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